Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 4/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.48 |
| ▸ | PLG | P00747 | 1/20 | 0.47 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.46 |
| ▸ | GRB2 | P62993 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | ALB | P02768 | 1/20 | 0.44 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.44 |
| ▸ | OXTR | P30559 | 1/20 | 0.44 |
| ▸ | FLT1 | P17948 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | CIB1 | Q99828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29773696 | 1.00 | KRAS (0.49) | KRASHDAC4PLGNTSR1GRB2 | |
| SCHEMBL29773704 | 1.00 | KRAS (0.49) | KRASHDAC4PLGNTSR1GRB2 | |
| SCHEMBL29884109 | 1.00 | KRAS (0.49) | KRASHDAC4PLGNTSR1GRB2 | |
| SCHEMBL29773756 | 0.97 | PLG (0.51) | KRASHDAC4PLGNTSR1HDAC3 | |
| SCHEMBL29884584 | 0.94 | KRAS (0.47) | KRASHDAC4PLGNTSR1GRB2 | |
| SCHEMBL30928172 | 0.94 | PLG (0.49) | KRASHDAC4PLGNTSR1GRB2 | |
| SCHEMBL29740322 | 0.94 | PLG (0.49) | KRASHDAC4PLGNTSR1GRB2 | |
| SCHEMBL21303808 | 0.94 | PLG (0.49) | KRASHDAC4PLGNTSR1GRB2 | |
| SCHEMBL29884013 | 0.94 | PLG (0.49) | KRASHDAC4PLGNTSR1GRB2 | |
| SCHEMBL29773718 | 0.94 | PLG (0.49) | KRASHDAC4PLGNTSR1GRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637348-A1 | DOUBLE ENCAPSULATED NANOCOMPOSITE FOR STAGED DELIVERY OF ACTIVE INGREDIENT(S), AND A METHOD OF PRODUCING THEREOF | Council Of Scientific & Industrial Research (IN) | 2025-10-29 | — | — | EP | claimed |
| EP-3755357-B1 | AN ANTIBIOTIC COMPOSITION COMPRISING MICELLES | SPOREGEN LTD (GB) | 2025-09-17 | — | — | EP | claimed |
| CN-120158470-A | Genetically engineered bacterium for producing iturin A and construction method and application thereof | 天津大学 | 2025-06-17 | — | — | CN | claimed |
| CN-115590980-B | Ganoderma lucidum spore capable of loading lactic acid bacteria and preparation method thereof | 西北工业大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119979429-A | Bacillus bailii engineering bacteria for improving iturin A yield and construction method thereof | 华中农业大学 | 2025-05-13 | — | — | CN | claimed |
| CN-112689758-B | Device and method for checking the effect of a drug on microorganisms | 上海宜晟生物科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119193650-A | Engineering bacterium for improving yield of toyogenin, construction method and application | 天津大学 | 2024-12-27 | — | — | CN | claimed |
| US-12171734-B2 | Pathogenic bacteria | SPOREGEN LIMITED (GB) | 2024-12-24 | — | — | US | claimed |
| CN-119074889-A | Application of iturin family lipopeptid in preparation of medicines for preventing and/or treating non-alcoholic fatty liver disease | 河北省科学院生物研究所 | 2024-12-06 | — | — | CN | claimed |
| CN-116179436-B | Lipopeptide mixture with broad-spectrum antibacterial activity and application thereof | 福建省农业科学院资源环境与土壤肥料研究所 | 2024-11-22 | — | — | CN | claimed |
| EP-4132571-A1 | RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS | Hofseth Biocare ASA (NO) | 2023-02-15 | — | — | EP | claimed |
| CN-115590980-A | Ganoderma lucidum spore capable of loading lactic acid bacteria and preparation method thereof | 西北工业大学（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-112694994-B | Bacillus belgii and method for co-production of vitamin K2 and iturin A | 新疆阜丰生物科技有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115427067-A | Respiratory therapy using salmon oil compositions | 霍夫赛思生物保健有限公司 | 2022-12-02 | — | — | CN | claimed |
| WO-2022228058-A1 | APPLICATION OF ITURIN FAMILY LIPOPEPTIDES IN PEST CONTROL | 河北省科学院生物研究所 | 2022-11-03 | — | — | WO | claimed |
| CN-114891821-A | Bacillus D high-activity strain and construction method and application thereof | 南京农业大学 | 2022-08-12 | — | — | CN | claimed |
| WO-2022108883-A1 | RESPIRATORY TREATMENTS | HOFSETH BIOCARE ASA (NO) | 2022-05-27 | — | — | WO | claimed |
| CN-114404567-A | Application of frizzled protein 7 in enhancing intestinal barrier protection function | 华南农业大学 | 2022-04-29 | — | — | CN | claimed |
| CN-109709334-B | Method for analyzing effect of mineral substances in oil meal in fermentation production of iturin A by bacillus | 中国农业科学院油料作物研究所 | 2022-04-01 | — | — | CN | claimed |
| CN-112063673-B | Culture medium suitable for high yield of iturin A by fermentation of bacillus amyloliquefaciens and application | 湖北大学 | 2022-03-25 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12171734-B2 | Pathogenic bacteria | CLPP, CLPX, ANTXR2 | KRAS 3299/4885HDAC4 379/4885PLG 2209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.